MAPT and Cognitive impairment: While the Qβ-AT8 vaccine failed to reduce tau pathology or rescue any cognitive deficits, the Qβ-pT181 vaccine was highly potent at reducing tau pathology and rescuing cognitive function, with enhanced efficacy compared to Qβ-PHF1.29